Literature DB >> 2585222

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

J S Prendiville1, A A Hebert, M J Greenwald, N B Esterly.   

Abstract

A retrospective analysis of 21 consecutive patients hospitalized with either Stevens-Johnson syndrome or toxic epidermal necrolysis was carried out to assess morbidity and mortality rates and to establish the value of a specific management practice. Fourteen children with Stevens-Johnson syndrome and seven with toxic epidermal necrolysis were cared for at the Children's Memorial Hospital, Chicago, between 1978 and 1988. All were managed in a well-staffed medical ward or, when necessary, in the pediatric intensive care unit. Supportive measures included reverse barrier isolation, intravenous fluids and nutritional support, meticulous skin care, early detection and treatment of infection, and daily ophthalmologic examination. No patient was treated with systemic steroids. The mortality rate was zero. Eye complications, consisting of dry eyes or mild chronic symblepharon, were the most significant long-term sequelae.

Entities:  

Mesh:

Year:  1989        PMID: 2585222     DOI: 10.1016/s0022-3476(89)80736-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Reactive metabolites and adverse drug reactions: clinical considerations.

Authors:  Sandra R Knowles; Lori E Shapiro; Neil H Shear
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

2.  The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome: a review of past and current opinions.

Authors:  Brent Michaels
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

3.  Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome.

Authors:  C Léauté-Labrèze; T Lamireau; D Chawki; J Maleville; A Taïeb
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

4.  Scrotal temperature is increased in disposable plastic lined nappies.

Authors:  C J Partsch; M Aukamp; W G Sippell
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

5.  Intravenous immunoglobulin in the treatment of vancomycin-induced toxic epidermal necrolysis.

Authors:  Mohamed A El-Naggari; Hashim Javad; Alexander P Chacko; Anas A Abdelmogheth
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

Review 6.  Use of steroids for erythema multiforme in children.

Authors:  Alfred K Yeung; Ran D Goldman
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

7.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

8.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29

9.  Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.

Authors:  Kyeong Hwan Kim; Sung Wook Park; Mee Kum Kim; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2013-09-10

10.  Controversies in the Management of Cutaneous Adverse Drug Reactions.

Authors:  Yashpal Manchanda; Sudip Das; Aarti Sarda; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.